Literature DB >> 6231353

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens.

J H Phillips, A M Le, L L Lanier.   

Abstract

Lymphoid cells with natural killer (NK)-like function, morphology, and antigenic phenotype have been identified in a mixed lymphocyte culture generated by co-culture of human peripheral blood mononuclear cells with an allogeneic human B lymphoblastoid cell line CCRF-SB. The majority of these mixed lymphocyte (MLR)-response activated NK cells express the Leu-11 surface antigen, but do not express certain T cell-associated antigens (Leu-1, Leu-3, and Leu-4) or the mature monocyte specific antigen, Leu-M3. Unlike most freshly isolated Leu-11+ human NK cells, the MLR-activated Leu-11+ cells expressed class II major histocompatibility antigens, DR and DC. Concomitant with expression of class II gene products, the Leu-11+,DR+ NK cells demonstrate enhanced cytotoxicity against the NK-sensitive tumor cell line K562. The presence of mitotic cells in the Leu-11+,DR+ population and the acquisition of increased levels of transferrin receptor on the cell surface were further indicators of activation of these cells. The direct precursors of the MLR-activated Leu-11+,DR+ cell were Leu-11+ cells that lacked expression of another NK-associated antigen Leu-7, i.e., Leu-7-,11+. These studies provided a definitive identification of the "NK-like" cell in MLR cultures and thus allow quantitation and isolation of these cells for further study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231353      PMCID: PMC2187263          DOI: 10.1084/jem.159.4.993

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells.

Authors:  E Svedmyr; H Wigzell; M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

2.  Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.

Authors:  G Strassmann; F H Bach; J M Zarling
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

3.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.

Authors:  B Perussia; O Acuto; C Terhorst; J Faust; R Lazarus; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

4.  Characterization of an antigen expressed by human natural killer cells.

Authors:  J D Griffin; T Hercend; R Beveridge; S F Schlossman
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

5.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

6.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity.

Authors:  M Jondal; S Targan
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

8.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.

Authors:  T Cotner; J M Williams; L Christenson; H M Shapiro; T B Strom; J Strominger
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

9.  Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.

Authors:  W E Biddison; P E Rao; M A Talle; G Goldstein; S Shaw
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Characterization of the killer cell generated in the autologous mixed leukocyte reaction.

Authors:  M Goto; N J Zvaifler
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  39 in total

1.  Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.

Authors:  M Yanagisawa; M Kato; K Ikeno; T Kobayashi; Y Miyagawa; A Komiyama; T Akabane
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

2.  Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15.

Authors:  T Yamabe; K Takakura; K Sugie; Y Kitaoka; S Takeda; Y Okubo; K Teshigawara; J Yodoi; T Hori
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Phenotypic characterisation of peripheral blood lymphoid cells in people exposed to fibrous zeolite.

Authors:  M Ozesmi; A Karlsson-Parra; G Hillerdal; U Forsum
Journal:  Br J Ind Med       Date:  1986-12

5.  Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.

Authors:  P Hersey; M MacDonald; S Schibeci; C Burns
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.

Authors:  D Montagna; R Maccario; A G Ugazio; G Mingrat; G R Burgio
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

Authors:  L Matera; R Foa; F Malavasi; G Bellone; A Funaro; F Veglia; D Santoli
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  The phenotype of human placental macrophages and its variation with gestational age.

Authors:  J Goldstein; M Braverman; C Salafia; P Buckley
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

9.  Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.

Authors:  R A Littaua; A Takeda; J Cruz; F A Ennis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 10.  T cell targeting in cancer therapy.

Authors:  R L Bolhuis; E Sturm; E Braakman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.